-
-
-
-
-
-
-
Wolfe Research Assumes West Pharmaceutical (WST) at Outperform
-
-
-
-
-
-
-
TD Cowen Reiterates Top Pick on Halozyme Therapeutics (HALO)
-
-
-
-
-
-
-
Morgan Stanley Starts West Pharmaceutical (WST) at Equalweight, 'Valuation Rich'
-
-
-
-
-
-
-
West Pharma (WST) Tops Q3 EPS by 27c; raises guidance
-
-
-
-
-
-
-
West Pharma (WST) Declares $0.22 Quarterly Dividend; 0.4% Yield
-
-
-
-
-
-
-
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
-
-
-
-
-
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
-
434,574 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

